HIF1A and rectal cancer: To further establish the value of pharmacological inhibition of HIF-1α in increasing 5-FU sensitivity, we selected a patient with rectal cancer (male, Dukes’ C) who did not respond to 5-FU-based preoperative neoadjuvant chemotherapy.